Back to User profile » Dr Shannon S Zhang
Papers published by Dr Shannon S Zhang:
Commentary
CodeBreak 200: Sotorasib Has Not Broken the KRASG12C Enigma Code
Zhang SS, Lee A, Nagasaka M
Lung Cancer: Targets and Therapy 2023, 14:27-30
Published Date: 19 April 2023
Review
Spotlight on Furmonertinib (Alflutinib, AST2818). The Swiss Army Knife (del19, L858R, T790M, Exon 20 Insertions, “uncommon-G719X, S768I, L861Q”) Among the Third-Generation EGFR TKIs?
Zhang SS, Ou SI
Lung Cancer: Targets and Therapy 2022, 13:67-73
Published Date: 25 October 2022
Perspectives
Spotlight on Tepotinib and Capmatinib for Non-Small Cell Lung Cancer with MET Exon 14 Skipping Mutation
Brazel D, Zhang S, Nagasaka M
Lung Cancer: Targets and Therapy 2022, 13:33-45
Published Date: 13 May 2022
Commentary
Deconstructing ADAURA: It is Time to Forgo Adjuvant Platinum-Based Chemotherapy in Resected IB-IIIA EGFR+ NSCLC (Except with RB Alterations?) When Adopting Adjuvant Osimertinib
Zhang SS, Ou SI
Lung Cancer: Targets and Therapy 2022, 13:23-31
Published Date: 26 April 2022
Review
Spotlight on Sotorasib (AMG 510) for KRASG12C Positive Non-Small Cell Lung Cancer
Zhang S, Nagasaka M
Lung Cancer: Targets and Therapy 2021, 12:115-122
Published Date: 7 October 2021
Review
Spotlight on Mobocertinib (TAK-788) in NSCLC with EGFR Exon 20 Insertion Mutations
Zhang SS, Zhu VW
Lung Cancer: Targets and Therapy 2021, 12:61-65
Published Date: 12 July 2021